Sign In
Buy ANGN
$1.00
+0 (+0%)
At Close: Aug 31, 2023
Angion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia
12:05am, Thursday, 25'th Mar 2021
Topline data expected in the first half of 2021 Topline data expected in the first half of 2021
Angion Announces Partial Waiver of Certain Lock-up Restrictions
12:05am, Friday, 19'th Mar 2021
UNIONDALE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel s
ANGN Stock Price Increases Over 25% Pre-Market: Why It Happened
08:29am, Monday, 01'st Mar 2021
The stock price of Angion Biomedica Corp (NASDAQ: ANGN) is trading at over 25% pre-market. This is why it happened.
Angion to Participate in Upcoming March Investment Conferences
12:05am, Wednesday, 24'th Feb 2021
UNIONDALE, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel sm
UNIONDALE, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of
U.S. IPO Weekly Recap: Biotechs Flood The IPO Market In A 14 IPO Week
02:14am, Monday, 08'th Feb 2021
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. German chemicals group Atotech downsized and priced below the range to raise $498
